Integra LifeSciences Cor... (IART)

NASDAQ: IART · Real-Time Price · USD

16.86

0.42 (2.55%)

At close: May 02, 2025, 3:59 PM

16.95

0.50%

After-hours: May 02, 2025, 04:54 PM EDT

Integra LifeSciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	246.38M	276.4M	456.66M	513.45M	470.17M	198.91M	138.84M	174.94M	102.06M
Short-Term Investments	27.19M	32.69M	16.68M	n/a	n/a	12K	4.65M	1.52M	242K
Long-Term Investments	n/a	30.71M	567.34M	6.48M	n/a	3.46M	7.12M	2.49M	1.63M
Other Long-Term Assets	66.52M	27.48M	-510.15M	9.96M	11.28M	11.18M	12.79M	13.59M	10.11M
Receivables	272.37M	259.33M	263.46M	231.83M	225.53M	275.3M	265.74M	251.8M	148.19M
Inventory	429.09M	389.61M	324.58M	317.39M	310.12M	316.05M	280.35M	296.33M	217.26M
Other Current Assets	29.65M	32.64M	31.03M	n/a	162.1M	n/a	n/a	99.08M	27.67M
Total Current Assets	1.08B	1.06B	1.16B	1.15B	1.24B	858.17M	775.08M	822.15M	495.17M
Property-Plant & Equipment	549.76M	496.38M	459.59M	396.25M	371.16M	431.93M	300.11M	269.25M	222.37M
Goodwill & Intangibles	2.3B	2.12B	2.17B	2.16B	1.92B	1.99B	2.01B	2.1B	1.07B
Total Long-Term Assets	2.96B	2.72B	2.73B	2.63B	2.38B	2.45B	2.33B	2.39B	1.31B
Total Assets	4.04B	3.78B	3.89B	3.78B	3.62B	3.3B	3.11B	3.21B	1.81B
Account Payables	82.5M	92.33M	102.1M	61.84M	54.61M	113.09M	76.05M	93.97M	29.06M
Deferred Revenue	n/a	8.54M	7.25M	5.29M	5.28M	4.77M	3.76M	11.05M	6.81M
Short-Term Debt	607.08M	14.53M	52.75M	59.77M	146.25M	57.25M	22.5M	60M	n/a
Other Current Liabilities	232.55M	100.84M	65.41M	105.68M	105.94M	67.13M	75.69M	110.5M	34.97M
Total Current Liabilities	922.13M	306.98M	320.91M	340.02M	401.01M	331.31M	262.55M	348.91M	123.6M
Long-Term Debt	1.2B	1.49B	1.41B	1.5B	1.41B	1.3B	1.33B	1.78B	665M
Other Long-Term Liabilities	313.17M	192.24M	138.5M	120.26M	186.73M	125.07M	80.05M	53.77M	30.75M
Total Long-Term Liabilities	1.57B	1.89B	1.76B	1.76B	1.7B	1.56B	1.47B	1.9B	844.69M
Total Liabilities	2.49B	2.19B	2.09B	2.1B	2.1B	1.89B	1.73B	2.25B	968.29M
Total Debt	1.98B	1.68B	1.62B	1.65B	1.66B	1.46B	1.35B	1.84B	665M
Common Stock	916K	909K	905K	896K	893K	887K	880K	813K	777K
Retained Earnings	939.91M	946.86M	879.12M	698.57M	532.26M	398.57M	348.37M	285.19M	220.44M
Comprehensive Income	-27.57M	-15.11M	10.27M	-45.16M	-74.06M	-76.4M	-45.44M	-23.81M	-57.15M
Shareholders Equity	1.55B	1.59B	1.8B	1.68B	1.51B	1.42B	1.38B	962.31M	839.67M
Total Investments	27.19M	64.87M	567.34M	6.48M	n/a	3.46M	7.12M	4.01M	1.87M